Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $1.58M in the quarter ending September 30, 2024, a decrease of -5.87%. This brings the company's revenue in the last twelve months to $4.02M, down -42.41% year-over-year. In the year 2023, Petros Pharmaceuticals had annual revenue of $5.82M, down -2.83%.

• Revenue (ttm): $4.02M
• Revenue Growth: -42.41%
• P/S Ratio: 0.48
• Revenue / Employee: $191,542
• Employees: 21
• Market Cap: 3.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.82M	-169.67K	-2.83%
Dec 31, 2022	5.99M	-1.82M	-23.29%
Dec 31, 2021	7.81M	-1.75M	-18.29%
Dec 31, 2020	9.56M	-6.02M	-38.63%
Dec 31, 2019	15.58M	1.53M	10.86%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.